Home・Aktien・Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Geschlossen

BrancheGesundheitswesen

355.84 -0.79

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

351.81

Max

361.32

Schlüsselkennzahlen
By Trading Economics
Einkommen	-2.3M -13M
Verkäufe	59M 651M
KGV Branchendurchschnitt	42.923 57.002
EPS	2.62
Gewinnspanne	-2.043
Angestellte	7,450
EBITDA	1.2B 542M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-8.29% downside

Dividenden
By Acuity
Nächstes Ergebnis	28. Okt. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	522M 9.5B
Vorheriger Eröffnungskurs	356.63
Vorheriger Schlusskurs	355.84

Nachrichtenstimmung

By Acuity

15%

85%

29 / 340 Ranking in Healthcare

Bio-Rad Laboratories Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Aug. 2026, 19:26 UTC

Bio Rad Laboratories Inc shares are lower today, influenced by disappointing U.S. retail sales data that raised concerns about consumer demand and economic performance.

13. Aug. 2026, 19:31 UTC

Bio Rad Laboratories Inc shares are declining today, influenced by significant downward movement in the Life Sciences Tools & Services sub-sector.

11. Aug. 2026, 20:02 UTC

Bio Rad Laboratories Inc is trading higher, maintaining momentum after three consecutive gains. The price remains well above its 20-day moving average.

10. Aug. 2026, 19:26 UTC

Bio Rad Laboratories Inc shares are lower today, despite earlier gains. No specific news has been identified to explain the decline.

7. Aug. 2026, 23:56 UTC

Bio Rad Laboratories Inc. shares declined in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average.

6. Aug. 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are lower today, breaking a recent trend of gains. No specific news was identified to explain this decline.

5. Aug. 2026, 20:03 UTC

News

Bio Rad Laboratories shares are higher as RBC raises its price target to $370. Wells Fargo and Citigroup also updated their price targets to $330.

4. Aug. 2026, 22:02 UTC

News

Bio-Rad Laboratories shares are lower in after-market trading following a restructuring announcement and lowered full-year sales guidance despite strong second-quarter earnings.

3. Aug. 2026, 19:46 UTC

Bio Rad Laboratories Inc is trading higher, supported by broader market trends amid falling oil prices. The stock remains near the upper end of its one-month range.

30. Juli 2026, 20:09 UTC

Bio Rad Laboratories shares are trading roughly flat amid mixed economic signals, including lower-than-expected U.S. GDP growth and rising initial jobless claims.

29. Juli 2026, 18:01 UTC

Bio Rad Laboratories Inc shares are lower today, continuing a decline since Tuesday's close. The broader market reacts to rising crude oil prices and inflation concerns.

28. Juli 2026, 17:03 UTC

Bio Rad Laboratories Inc. shares are higher today, diverging from a declining Nikkei 225 Index amid concerns over tech stock sustainability and rising semiconductor production in China.

27. Juli 2026, 19:46 UTC

Bio Rad Laboratories Inc shares are higher today, reaching a session high as crude oil prices decline. No specific company news was identified.

24. Juli 2026, 19:11 UTC

Bio Rad Laboratories Inc shares are lower, impacted by declines in the Life Sciences Tools & Services sub-sector. Earlier, they rebounded from a session low.

23. Juli 2026, 20:03 UTC

Correlated Moves

Bio Rad Laboratories Inc shares are higher, supported by gains in the Life Sciences Tools & Services sector and positive sentiment from Thermo Fisher Scientific Inc.

22. Juli 2026, 20:07 UTC

Bio Rad Laboratories Inc shares are higher today, maintaining a position above their 20-day moving average and near the upper end of their one-month range.

21. Juli 2026, 16:26 UTC

News

Bio-Rad Laboratories Inc shares are lower amid negative sentiment surrounding Sartorius, which reported disappointing earnings from Danaher’s bioprocessing unit.

20. Juli 2026, 19:17 UTC

Correlated Moves

BIO shares lower; iShares U.S. Healthcare ETF declines during session.

Peer-Vergleich

Kursveränderung

Bio-Rad Laboratories Inc Prognose

Kursziel

By TipRanks

-8.29% Nachteil

12-Monats-Prognose

Durchschnitt 331.25 USD -8.29%

Hoch 390 USD

Tief 275 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bio-Rad Laboratories Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Bio-Rad Laboratories Inc – Dist abgegeben haben.

Stimmung

By Acuity

29 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.